-
Impact of a Digital Musculoskeletal Program on Healthcare Spending Among Participants with Chronic Musculoskeletal Pain and Comorbidities
Mar 10, 2025, 14:00 PM -
Healthcare Costs and Resource Utilization Associated With Knee Osteoarthritis and Obesity in the United States: A Retrospective Database Study
Mar 10, 2025, 14:00 PM -
The Economic Burden of Illness for Patients with Idiopathic Pulmonary Fibrosis Utilizing Treatment Cohorts: A US Retrospective Claims Study
Mar 10, 2025, 14:00 PM -
US Food and Drug Administration Authorizations of Therapeutic Biologics and Biosimilars, 1980-2024
Mar 10, 2025, 14:00 PM -
Measuring the Spillover Effect of Cancer on Family Members' Health: A US-Based Empirical Analysis
Mar 10, 2025, 14:00 PM -
Parametric Model Selection: Beyond AIC/BIC in Health Economic Context
Mar 10, 2025, 14:00 PM -
Trends in Antidiabetic Medication Use and Outpatient Pharmacy Costs in a Commercially Insured Diabetes Population from a US Payer Perspective
Mar 10, 2025, 14:00 PM -
Geographic Variation in Lower Limb Prosthesis Prescription Disparities Between White and Black Veterans: A Retrospective Cohort Analysis (2010 - 2022)
Mar 10, 2025, 14:00 PM -
Coverage Gaps: Do U.S. Commercial Health Plans Have Concordant Alzheimer's Disease Therapy & Testing Policies?
Mar 10, 2025, 14:00 PM -
Novel Therapies for Neurofibromatosis Type 1-Associated Inoperable Plexiform Neurofibromas: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Incidence, Prevalence, and Risk Factors of Giant Cell Arteritis: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
US Physician Characteristics Associated With Real-World Evidence Implementation in Oncology Practice
Mar 10, 2025, 14:00 PM -
Development and Application of a Novel Framework for Clinician Stakeholder Engagement in Real-world Data (RWD) Studies
Mar 10, 2025, 14:00 PM -
Characteristics of Patients With Minimal Residual Disease (MRD) Testing for Solid Tumors in a United States Population With Commercial or Medicare Advantage (MA) Insurance
Mar 10, 2025, 14:00 PM -
Estimated Public Health Impact of Adjuvanted RSVPreF3 Vaccination in US Adults Aged 18-49 Years Who Are at Increased Risk for Severe RSV Disease
Mar 10, 2025, 14:00 PM -
ICER Thresholds in Cost-Utility Analysis: Assessing Conceptual Relevance and Practical Adequacy for Drug Reimbursement Decision-Making in The US
Mar 10, 2025, 14:00 PM -
Burden of Illness in CIDP: Results of a Multinational Real-World Survey
Mar 10, 2025, 14:00 PM -
A Conceptual Model of Multiple Myeloma Symptoms and Impacts, and A Characterization of Pain Among Patients Living With Relapsed/Refractory Multiple Myeloma
Mar 10, 2025, 14:00 PM -
Clinical Validation of Large Language Model for Automated Extraction of Genetic Testing Data
Mar 10, 2025, 14:00 PM -
Productivity Loss And Indirect Costs Of Heart Failure: Analysis Of The Brazilian Social Security System
Mar 10, 2025, 14:00 PM
